Growth differentiation factor-15 and its role in diabetes and cardiovascular disease

Adrian C Eddy1, Aaron J Trask2

  • 1Center for Cardiovascular Research, The Heart Center, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.

Insights

Growth Differentiation Factor-15 (GDF-15) is a cytokine with a dual role. While elevated GDF-15 indicates cardiovascular disease and diabetes, it also offers protective effects in inflammation and metabolic regulation.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Cardiology

Background:

  • Growth Differentiation Factor-15 (GDF-15) is a cytokine implicated in various physiological processes.
  • Elevated GDF-15 levels are frequently observed in cardiovascular disease (CVD) and diabetes mellitus, suggesting its potential as a biomarker.
  • Contradictory findings indicate GDF-15 possesses protective functions in inflammation, endothelial health, insulin sensitivity, and myocardial infarction (MI).

Purpose of the Study:

  • This review focuses on the multifaceted roles of GDF-15.
  • It explores the signaling pathways through which GDF-15 influences metabolism, insulin sensitivity, and cardiovascular function.
  • The review aims to reconcile the seemingly opposing roles of GDF-15 in disease pathogenesis and protection.

Main Methods:

  • Literature review of existing studies on GDF-15.
  • Analysis of signaling pathways involved in GDF-15 regulation and function.
  • Synthesis of data regarding GDF-15's impact on metabolic and cardiovascular systems.

Main Results:

  • GDF-15 exhibits complex regulatory functions, acting as both a marker of disease and a protective factor.
  • Its signaling pathways are crucial for modulating inflammation, insulin resistance, and cardiac protection.
  • Evidence suggests GDF-15 plays a significant role in maintaining metabolic homeostasis and cardiovascular health.

Conclusions:

  • GDF-15's role in metabolic and cardiovascular regulation is intricate and context-dependent.
  • Understanding GDF-15 signaling pathways is key to elucidating its therapeutic potential.
  • Further research is warranted to fully characterize GDF-15's functions and its clinical applications in metabolic and cardiovascular diseases.

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.1K